THE LATEST WORD

Top Industry Stories – June 25, 2010

Posted on June 25th, 2010 | by Rxmedyn | No Comments »

House Passes Plan to Stop Medicare Cuts to Doctors

J&J Plant Involved in Recall to Stay Closed

P&G Recalls Nasal Spray Sold in U.S. Stores

Kowa’s US CEO Says New Statin Holds Appeal for Untreated Patients

Native Americans Embrace Tradition to Defeat Diabetes

Read the rest of this entry »

Top Industry Stories – May 11, 2010

Posted on May 11th, 2010 | by Rxmedyn | No Comments »

Obesity Task Force Urges Action

U.S. Group Urges FDA to Halt Glaxo’s Avandia Trial

Health Overhaul Law Potentially Costs $115B More

First Lady Releases Child Obesity Recommendations

Merck: Schering-Plough Integration is on Track

How’s My Detailing? Dial 1-877-RX-DDMAC

Consumers Want Unbranded Sites, Despite FDA Warnings

Top Industry Stories – April 21, 2010

Posted on April 21st, 2010 | by Rxmedyn | No Comments »

Colin Powell and Bill Gates Join Malaria Campaign

Merck Inks Deal on Tetanus, Diphtheria Vaccine

Abbott First-Quarter Profit Falls as Costs Increase

Senate Bill Sets a Plan to Regulate Premiums

Drug Maker Elan Narrows Loss

Read the rest of this entry »

Top Industry Stories – April 20, 2010

Posted on April 20th, 2010 | by Rxmedyn | No Comments »

Changing Old Habits Could Save Big On Drug Costs

Biogen First-Quarter Profit Drops on Higher Research

J&J First-Quarter Profit Rises on Device Sales Gains

Benefit for Uninsured May Still Pose Hurdle

Cancer Fight: Unclear Tests for New Drug

Read the rest of this entry »

Top Industy Stories 2.10.10

Posted on February 10th, 2010 | by Rxmedyn | No Comments »

Usana 4Q profit doubles on lower general costs (Associated Press)

GSK reveals plans to trim workforce at UK research site (Pharmatimes.com)

Sanofi-Aventis Q4 Profit Up on Swine Flu Vaccines (Associated Press)

Blow for Novartis and B-MS as NICE rejects Afinitor, Tasigna and Sprycel (Pharmatimes.com)

Read the rest of this entry »

Top Industry Stories – 2.9.10

Posted on February 9th, 2010 | by Rxmedyn | No Comments »

Emerging social network Foursquare plans to launch a partnership with Zagat (PR Week)
Takeda Launches Osteosarcoma Medicine Mepact in EU (Oncology Weekly)
FDA OK’s Wider Use of AstraZeneca’s Crestor (PharmaTimes)
Novartis buys rights to Debiopharm’s “Hep C” drug (PharmaTimes)

Read the rest of this entry »

Top Industry Stories- January 6, 2010

Posted on January 6th, 2010 | by Rxmedyn | No Comments »

Top Industry Stories – October 22, 2009

Posted on October 22nd, 2009 | by Rxmedyn | No Comments »

Wellstat Therapeutics and Sanofi-aventis Enter Agreement On Novel Therapy for Type II Diabetes (Business Wire)

Synovis Life Technologies Receives CE Mark Approval for the Use of Veritas ® Collagen Matrix

in Hernia Repair and Breast Reconstruction (Business News)

Teva Seeks To Sell Generic Version Of Bristol HIV Drug (Nasdaq)

Read the rest of this entry »

Top Industry stories – October 21, 2009

Posted on October 21st, 2009 | by Rxmedyn | No Comments »

Mixed Reviews For New Parkinson’s Drug (VisitBulgaria)
Ethicon Endo-Surgery launch one-handed articulating endocutter (MTBEurope.info)
Pfizer Won’t Share Wyeth’s Q3 Numbers; Layoff Announcements Due This Week (Industry.bnet.com)

Read the rest of this entry »

Top Industry Stories – October 21, 2009

Posted on October 21st, 2009 | by Rxmedyn | No Comments »

Eli Lilly Swings To 3Q Profit Amid Year-Ago Zyprexa Charge (Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Pfizer earnings up 26% despite lower sales of many drugs (Pharma Times)

Biogen profits leap as Tysabri sales soar again (Pharma Times)

Read the rest of this entry »